IL6 and neoplasm: Elevated levels of IL-6, which is secreted by activated CAFs, particularly FAP + CAFs, contribute to the proliferation of immunosuppressive cells, impairment of anti-tumor cell functions, and ultimately, tumor progression and therapy resistance through various downstream signaling pathways [17, 49, 118, 158, 173, 178].